未登录

M

Michael D. Jensen

mayo clinic

H指数:99

被引数:5.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stopping Spin at the Source: Learning From an Example in Obesity

从肥胖案例中学习：从源头阻止宣传

IF4.7

2026-04-120

PRE

Meal fatty acid metabolism is associated with long-term weight gain in women – a retrospective cohort study

The American Journal of Clinical Nutrition

IF6.9

2026-01-290

PRE

Effects of dapagliflozin on body composition and its relation to hemodynamics in heart failure with preserved ejection fraction: the CAMEO-DAPA randomized clinical trial

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction

Dapagliflozin增强了射血分数保留的心力衰竭运动期间的动脉和静脉顺应性

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial

IF38.6

2024-09-241

PRE

Dapagliflozin and Right Ventricular-Pulmonary Vascular Interaction in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of a Randomized Clinical Trial

JAMA CARDIOLOGY

IF14.1

2024-09-013

PRE

Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction

Dapagliflozin，肽YY和保留射血分数的心力衰竭的体重减轻

EUROPEAN HEART JOURNAL

IF35.6

2024-08-211

PRE

Clarification of our response to The importance of diversity in Obesity articles

澄清我们对肥胖文章多样性重要性的回应

IF4.7

2024-07-240

PRE

Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis

JOURNAL OF LIPID RESEARCH

IF4.1

2024-07-011

OAAI

Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction

达格列净对射血分数保留的心力衰竭患者体成分的影响及其与血流动力学的关系

IF38.6

2024-06-183

PRE

Optimal Measures of Insulin-Regulated Lipolysis in Humans

IF7.5

2024-06-140

PRE

Adipose Tissue Perilipin 1 Insulin Responsiveness in Obesity

IF7.5

2024-06-140

PRE

Insulin regulation of regional lipolysis in upper-body obese and lean humans

IF6.1

2024-04-113

OA

Adipose Tissue Analysis Toolkit (ATAT) for automated analysis of adipocyte size and extracellular matrix in white adipose tissue

IF4.7

2024-02-063

OAAI

Response to The importance of diversity in Obesity articles

对肥胖文章多样性重要性的回应

IF4.7

2024-01-140

PRE

Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2023-09-271

PRE

Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial

IF38.6

2023-09-0540

OA

Muscle Lipid Turnover Predicts Aerobic Training Effects on Body Composition

IF7.5

2023-06-200

PRE

Local Muscle Microenvironment, Instead of Training Status, Affects Resting IMTG Turnover

IF7.5

2023-06-200

PRE

Adipose Tissue Protein Response and Insulin Sensitivity in Obesity

IF7.5

2023-06-200

PRE